Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Experimental Intranasal DNA Vaccine Targeting Drug-Tolerant Tuberculosis Bacteria July 19, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have unveiled a groundbreaking experimental therapeutic DNA vaccine for tuberculosis (TB), delivered non-invasively through the nose.…
Sexual Health & Medical Wellness Zoliflodacin Emerges as a Potential Game-Changer in the Global Fight Against Drug-Resistant Gonorrhea July 17, 2026 Susilo Ahmad Researchers are heralding a significant breakthrough in the treatment of gonorrhea, a widespread sexually transmitted infection, with a new oral medication named zoliflodacin demonstrating remarkable efficacy in late-stage clinical trials.…
Psychology & Intimacy Prucalopride, a Chronic Constipation Drug, Shows Promise in Alleviating Lingering Cognitive Deficits in Depression July 16, 2026 Rebecca Shoemaker People grappling with depression often find that even after their mood significantly improves, they are left with a persistent burden of cognitive challenges. These lingering symptoms can include profound memory…
Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Novel Intranasal DNA Vaccine Targeting Drug-Tolerant Tuberculosis July 12, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have achieved a significant breakthrough in the fight against tuberculosis (TB), developing an experimental therapeutic DNA…
Sexual Health & Medical Wellness Zoliflodacin Emerges as Promising Single-Dose Oral Treatment Against Growing Threat of Drug-Resistant Gonorrhea July 10, 2026 Susilo Ahmad Researchers are testing a new oral medication called zoliflodacin that could offer a simpler way to treat gonorrhea, especially strains that no longer respond well to existing antibiotics. In a…
Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Novel Intranasal DNA Vaccine Targeting Drug-Tolerant TB Bacteria, Offering New Hope Against Global Health Scourge. July 5, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have achieved a significant breakthrough in the fight against tuberculosis (TB), developing an experimental therapeutic DNA…
Sexual Health & Medical Wellness New antibiotic pill shows promise against drug-resistant gonorrhea July 3, 2026 Susilo Ahmad Researchers are heralding a significant advancement in the global fight against gonorrhea, with a new oral medication, zoliflodacin, showing exceptional promise in late-stage clinical trials. Published in the esteemed medical…
Sexual Health & Medical Wellness Zoliflodacin Emerges as a Promising Single-Dose Oral Treatment Against Growing Threat of Drug-Resistant Gonorrhea June 25, 2026 Susilo Ahmad Researchers are testing a new oral medication called zoliflodacin that could offer a simpler way to treat gonorrhea, especially strains that no longer respond well to existing antibiotics. In a…
Sexual Health & Medical Wellness A New Oral Medication, Zoliflodacin, Shows Promise in Late-Stage Trials, Offering a Potential Breakthrough Against Drug-Resistant Gonorrhea. June 17, 2026 Susilo Ahmad Researchers are making significant strides in the fight against gonorrhea, with a new oral medication called zoliflodacin demonstrating remarkable efficacy in a late-stage Phase 3 clinical trial. Published in the…
Psychology & Intimacy Potential Anti-Aging Drug Combination Linked to Significant Brain Damage in Mice June 16, 2026 Rebecca Shoemaker A widely researched drug combination lauded for its anti-aging potential has revealed a concerning and potentially serious downside, according to new findings from the University of Connecticut. The treatment, a…
